Theravance Biopharma (TBPH) Gross Profit (2013 - 2018)
Theravance Biopharma (TBPH) recorded Gross Profit of $15.11 million in Q4 2018, up 581.9% from $2.22 million a year earlier and up 24.5% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Gross Profit (2013 - 2018) Analysis & Trends
For FY2018, Theravance Biopharma reported Gross Profit of $59.66 million, up 537.6% from FY2017.
- Annual Gross Profit has a five-year compound annual growth rate of 205.0% (FY2013 to FY2018).
- Across earlier years, Gross Profit came in at $9.36 million in FY2017 (-79.6%), $45.75 million in FY2016 (+22.1%), $37.47 million in FY2015 (+391.1%) and $7.63 million in FY2014.
- Quarterly Gross Profit has ranged from -$1.79 million in Q4 2014 to $22.03 million in Q2 2018 over the past five years.
- On a year-over-year basis, Gross Profit has increased for four consecutive quarters, with growth averaging 212.5% over the last eight quarters.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 926.9% in Q2 2018, against a decline of 85.7% in Q1 2017 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.13 million (Q3 2018), $22.03 million (Q2 2018) and $7.49 million (Q1 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 15.11 Mn |
| Sep 30, 2018 | 12.13 Mn |
| Jun 30, 2018 | 22.03 Mn |
| Mar 31, 2018 | 7.49 Mn |
| Dec 31, 2017 | 2.22 Mn |
| Sep 30, 2017 | 3.29 Mn |
| Jun 30, 2017 | 2.15 Mn |
| Mar 31, 2017 | 2.52 Mn |
| Dec 31, 2016 | 4.55 Mn |
| Sep 30, 2016 | 18.74 Mn |
| Jun 30, 2016 | 4.83 Mn |
| Mar 31, 2016 | 17.63 Mn |
| Dec 31, 2015 | 692,000.00 |
| Sep 30, 2015 | 10.12 Mn |
| Jun 30, 2015 | 6.63 Mn |
| Mar 31, 2015 | 20.03 Mn |
| Dec 31, 2014 | -1.79 Mn |
| Sep 30, 2014 | 5.97 Mn |
| Jun 30, 2014 | 2.70 Mn |
| Mar 31, 2014 | 757,000.00 |
API Access
Theravance Biopharma Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();